AstraZeneca strikes drug discovery collaboration deal with Orca Pharmaceuticals
Wragge Lawrence Graham & Co life sciences experts have advised long-standing client AstraZeneca on a three-year drug discovery collaboration agreement with Orca Pharmaceuticals. The agreement will give AstraZeneca access to inhibitors of acid-related orphan nuclear receptor gamma (RORg) developed by Orca Pharmaceuticals with the potential to treat a range of autoimmune disorders. The collaboration combines the scientific […]